PMC:7534795 / 0-151
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T65995 | 24-35 | Body_part | denotes | fatty acids | http://purl.org/sig/ont/fma/fma82738 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 83-91 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T98443 | 50-51 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T1 | 8-35 | Chemical | denotes | polyunsaturated fatty acids | http://purl.obolibrary.org/obo/CHEBI_26208 |
| T2 | 24-35 | Chemical | denotes | fatty acids | http://purl.obolibrary.org/obo/CHEBI_35366 |
| T3 | 30-35 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
| T4 | 62-70 | Chemical | denotes | adjuvant | http://purl.obolibrary.org/obo/CHEBI_60809 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-132 | Sentence | denotes | Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications? |
| T2 | 134-142 | Sentence | denotes | Abstract |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 3 | 4-35 | Chemical | denotes | N-3 polyunsaturated fatty acids | MESH:D015525 |
| 4 | 83-91 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 5 | 103-131 | Disease | denotes | cardiovascular complications | MESH:D002318 |